Novel JAK Inhibitors Under Investigation for IBD

Описание к видео Novel JAK Inhibitors Under Investigation for IBD

Earn CME for this activity: https://www.naccme.com/program/21-aib...

Although the rapidly expanding IBD treatment armamentarium offers vastly improved opportunities to achieve treatment goals, it may also complicate treatment decisions. Clinicians who care for patients with IBD must understand how to maximize current therapies and effectively integrate newer therapies as they emerge as well as how to utilize objective measures of response in high-risk patients in order to better align their treatment with current best practices.

© 2021 Imedex, an HMP Company

Комментарии

Информация по комментариям в разработке